Company / Return on Assets (ROA)
NEUROONE MEDICAL TECHNOLOGIES Corp Return on Assets (ROA) History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-114.2%
FY2025
5-year range
-286.6% / -77.6%
FY2021-FY2025
Trend
+48.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) returned to growth in FY2025 after 2 years of decline, reaching -114.2%.
Based on SEC 10-K filings.
-114.2% in FY2025 with a 10-year CAGR of +1857.7%.
Improved from -123.5% to -114.2% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -36.6pp
- 5-Year Change
- -
- 10-Year Change
- +1857.7pp
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 48.3% year-over-year.
- Peak return on assets (roa) was recorded in FY2011.
- Lowest return on assets (roa) in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -114.2% | +48.3% |
| FY2024 | -220.8% | -78.8% |
| FY2023 | -123.5% | -59.2% |
| FY2022 | -77.6% | +72.9% |
| FY2021 | -286.6% | +80.5% |
| FY2016 | -1469.8% | +25.5% |
| FY2015 | -1971.9% | +86.8% |
| FY2014 | -14904.4% | -503.6% |
| FY2012 | -2469.1% | -5557.8% |
| FY2011 | -43.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026